Do you think you know the ins-and-outs of federal support for biotech innovators and startups? It is a vast area and goes far beyond SBIR grants and includes diverse support and funding mechanisms through a variety of federal agencies.

Join us for an in-person session with representatives from the National Cancer Institute (NCI), National Center for Advancing Translational Sciences (NCATS), as well as the Biomedical Advanced Research and Development Authority (BARDA) and the Federal Drug Administration Office of Science and Engineering Laboratories (OSEL). Along with providing an overview of the organizations support mechanisms, agencies will also be available for one-on-one meetings to answer specific questions you may have about the submission process.

Companies interested in being considered for a one-on-one in-person, 20-minute meetings following the event will need to apply for consideration by June 19. Selected companies will be notified on June 23.